Structure |
Chemical Name |
CAS |
MF |
|
Diquafosol Impurity 13 |
211448-81-6 |
C18H28N4O29P6 |
|
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
|
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
|
Oxacillin Impurity F |
5053-35-0 |
C19H19N3O4S2 |
|
Peramivir Impurity 30 |
2758048-79-0 |
C20H36N2O6 |
|
NICERGOLINE IMP. D (EP): 5-BROMOPYRIDINE-3-CARBOXYLIC ACID |
|
|
|
AMOXICILLIN TRIHYDRATE IMP. D (EP) AS SODIUM SALT:(4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]-CARBOXYMETHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID SODIUM SALT (PENICILLOICACIDS OF AMO |
1642629-94-4 |
C16H21N3O6S |
|
4-CHLORO-6-(2-CHLORO-ETHOXY)-7-(2-METHOXY-ETHOXY)-QUINAZOLINE |
183322-19-2 |
C13H14Cl2N2O3 |
|
2-PIPERAZINE-4-AMINO-6,7-DIMETHOXY QUINOLINE HYDROCHLORIDE |
84050-22-6 |
C14H20ClN5O2 |
|
2-CHLORO-N-(2,3-DIMETHYL-PHENYL)-ACETAMIDE |
2564-07-0 |
C10H12ClNO |
|
1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl)-pyridine-3,5-dicarboxylic acid monoisopropyl ester |
116983-17-6 |
C18H20N2O6 |
|
Cabozantinib impurity 37 |
|
|
|
4-(1-bromoethyl)-6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidine |
|
|
|
ethyl 6-bromo-4,7-bis((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate |
|
|
|
Dapoxetine impurity 53 |
|
|
|
Dapoxetine impurity 70 |
|
|
|
Bosutinib Impurity 38 |
2095306-26-4 |
C46H44Cl4N8O6 |
|
(2RS)-2-(4-ETHYLPHENYL)PROPANOIC ACID |
3585-52-2 |
C11H14O2 |
|
2-Thiopheneacetic acid, α-hydroxy-α-2-thienyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester |
320347-97-5 |
C17H19NO3S2 |
|
4,4′-DIPHENOQUINONE (DQ) |
494-72-4 |
C12H8O2 |
|
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
|
ACETYLSIMVASTATIN |
145576-25-6 |
C27H40O6 |
|
5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE |
120568-11-8 |
C14H12N4 |
|
L-2-Aminobutanamide |
7324-11-0 |
C4H10N2O |
|
AMIKACIN IMPURITY A |
|
|
|
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
|
GLICLAZIDE IMPURITY F |
|
|
|
ONDANSETRON IMPURITY D |
|
|
|
PERINDOPRIL IMPURITY A |
|
|
|
decyl D-glucoside |
54549-25-6 |
C16H32O6 |
|
3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(3-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
|
1-benzyl-4-phenylpiperidin-4-ol |
63843-83-4 |
C18H21NO |
|
[(±)-(4-amino-2-hydroxy-4-oxobutyl)trimethylammonium] chloride |
5261-99-4 |
C7H18ClN2O2+ |
|
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
|
17,21-dihydroxy-16beta-methylpregna-1,4,9(11)-triene-3,20-dione |
13504-15-9 |
C22H28O4 |
|
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N'-propyl- |
2300968-87-8 |
C19H21BrN6O4S |
|
Benzeneacetonitrile, 4-(4-chloro-1-oxobutyl)-α,α-dimethyl- |
169032-17-1 |
C14H16ClNO |
|
Oseltamivir Impurity 103 |
|
|
|
Oseltamivir Impurity 101 |
|
|
|
Oseltamivir Impurity 90 |
|
|
|
Oseltamivir Impurity 79 |
|
|
|
Oseltamivir Impurity 73 |
|
|
|
Oseltamivir Impurity 69 |
|
|
|
10-methoxy-6-methylergoline-8beta-methanol |
35121-60-9 |
C17H22N2O2 |
|
INDEX NAME NOT YET ASSIGNED |
2514957-39-0 |
C16H16FN3O4 |
|
Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester |
127373-95-9 |
C21H24N2O7S |
|
Fulvestrant Impurity 1 |
|
|
|
CefazolinH020-02-I-02 |
|
|
|
(E)-3-[cyano(2,3-dichlorophenyl)methylene]carbazamidine |
94213-24-8 |
C9H7Cl2N5 |
|
5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]- |
2606144-44-7 |
C16H18N6O2 |
|
3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo- |
1395471-26-7 |
C23H26FN3O5 |
|
(1S,5R)-9-(4-fluorophenyl)-11-isopropyl-10-phenyl-1,2,6,7-tetrahydro-3H,5H-1,5-methanopyrrolo[1,2-e][1,5]oxazonin-3-one |
|
|
|
N-[3-acetyl-4-(oxiranylmethoxy)phenyl]butyramide |
28197-66-2 |
C15H19NO4 |
|
8-isopropyl-8-azabicyclo[3.2.1]octan-3-one |
3423-28-7 |
C10H17NO |
|
Mosapride Citric Amide |
1215825-20-9 |
C27H31ClFN3O9 |
|
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
39925-19-4 |
C8H11N3O6 |
|
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
|
4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one |
124379-29-9 |
C16H12Cl2O |
|
(4-(2-(azepan-1-yl)ethoxy)phenyl)Methanol |
223251-16-9 |
C15H23NO2 |
|
4-HYDROXY PROPOFOL |
1988-10-9 |
C12H18O2 |
|
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
|
benzbroMarone iMpurity |
|
|
|
Dasatinib iMpurity |
1184919-23-0 |
C22H27N7O2S |
|
eszopiclone iMpurity |
|
|
|
IMidafenacin iMpurity |
503599-41-5 |
C18H20N2O2 |
|
latanoprost iMpurity |
733036-95-8 |
C25H35FO5 |
|
Irbesartan IMpurity D |
|
C25H28N6O |
|
Ondansetron HCl IMpurity-G |
99614-03-6 |
C17H17N3O |
|
lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate |
1421227-96-4 |
C9H11LiO4S |
|
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetaMide) |
120512-03-0 |
C17H21N5O |
|
AtracuriuM IMpurity I (Mixture of cis, trans(I1), cis, cis(I2), tans, trans IsoMer) |
|
|
|
(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine |
147769-93-5 |
C16H26N2 |
|
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
|
Ceftriaxone Sodium impurity 3 |
|
|
|
Sugammadex sodium Monoiodo Impurity |
|
|
|
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
|
Avatrombopag Impurity 22 |
570403-14-4 |
C31H38Cl2N6O3S2 |
|
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
|
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
|
DexMedetoMidine IMpurity 16 |
|
|
|
Canagliflozin Impurity 2 |
|
|
|
Rivaroxaban Impurity 22 |
|
|
|
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
|
Ezetimibe Impurity 33 |
|
|
|
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
|
Vonoprazan Impurity U4 |
|
|
|
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
|
Parecoxib SodiuM iMpurity 37 |
|
|
|
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
|
Apixaban Impurity BMS-A |
|
|
|
Afatinib Impurity 70 |
125781-04-6 |
C4H7ClO2 |
|
Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid |
1704504-93-7 |
C20H18N4O4 |
|
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
|
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
|
Tenofovir Impurity 71 |
|
|
|
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
|
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
|
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)- |
2243233-98-7 |
C46H55NO14 |
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
|
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |